Managing Editor, Europe
Latest From Tom Gallen
Returning demand for cough & cold products and nasal sprays has lifted Recordati's OTC sales by 14% in the first nine months of 2022.
A round-up of the latest moves in the consumer health market: Reckitt has appointed former Sky chief exec Jeremy Darroch to its board; Genomma Lab is promoting COO Marco Sparvieri to the role of CEO; and Alliance Pharma has announced CEO Peter Butterfield is taking a short period of absence from the company.
Ireland’s drug regulator HPRA has initiated a formal regulatory procedure to determine if OTC remains the appropriate classification for codeine-containing products. The agency says the move is in response to a growing understanding of the potential impacts of addiction to codeine at low doses.
The trophies have been handed out at the OTC Marketing Awards 2022 - but what did the expert judges have to say about the winning and highly-commended entries?
Winners across 15 categories were announced at the OTC Marketing Awards 2022 on 28 November, with Haleon crowned OTC Company of the Year.
Concerns over addiction to, and deliberate misuse of, codeine in Estonia has led the national regulator to reverse-switch the opioid from OTC to prescription-only status.